Wenzheng Yu
Binzhou, 256600, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Global research landscape and thematic transitions in pyruvate kinase deficiency: a decadal bibliometric analysis (2015-2025).
Journal: Frontiers in medicine
Published: April 26, 2026
Orelabrutinib versus chemoimmunotherapy in treatment-naïve chronic lymphocytic leukemia/small lymphocytic lymphoma: a randomized, phase 3 trial.
Journal: Signal transduction and targeted therapy
Published: December 23, 2025
Caffeic acid tablets plus high-dose dexamethasone versus placebo plus high-dose dexamethasone in patients with newly diagnosed immune thrombocytopenia: A multicenter, double-blind, randomized, controlled, phase 2 trial.
Journal: Chinese medical journal
Published: April 22, 2025
Prognostic Factors in Acute Myeloid Leukemia with t(8;21)/AML1-ETO: Strategies to Define High-Risk Patients.
Journal: Indian journal of hematology & blood transfusion : an official journal of Indian Society of Hematology and Blood Transfusion
Published: July 24, 2021
High-dose dexamethasone plus recombinant human thrombopoietin vs high-dose dexamethasone alone as frontline treatment for newly diagnosed adult primary immune thrombocytopenia: A prospective, multicenter, randomized trial.
Journal: American journal of hematology
Published: February 19, 2020
A prospective, multicenter study of low dose decitabine in adult patients with refractory immune thrombocytopenia.
Journal: American journal of hematology
Published: August 01, 2019
miR-186 inhibits cell proliferation in multiple myeloma by repressing Jagged1.
Journal: Biochemical and biophysical research communications
Published: November 23, 2015
Prospective multicentre study of chemotherapeutic regimen containing pirarubicin on the treatment of relapsed or refractory acute myeloid leukemia in adults
Journal: Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi
Published: May 27, 2014
Showing 1-8 of 8
Last Updated: 09/26/2026